Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Russia patents space station designed to generate artificial gravity - 2Zelensky confidant dismissed from further posts amid bribery scandal
- 3Smooth out Your Funds: Cash The board Simplified
- 4Earthquake in Indonesia kills at least 1 person and sets off small tsunami
- 5Partner of crime boss Steven Lyons arrested in Dubai
- Well informed: How to Take full advantage of Your Gadgets
- Believe Should Unwind? Look at These Scaled down Games
- Best Exciting ride: Which One Rushes You the Most?
- Winter storm headed for Midwest to Northeast. Here's how much snow to expect.
- 'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran
- Can humans have babies in space? It may be harder than expected
- 100 new alien worlds: Scientists find hidden haul in data from NASA exoplanet-hunting spacecraft
- New peace laureate: Iran's arrest of Mohammadi 'confession of fear'
- Cheetos and Doritos to launch new versions without artificial dyes
